Astrocytes or astroglia are heterogeneous cells, similar to neurons, that have different properties in different brain regions. The implications of steroid hormones on glial cells and stress-related pathologies have been studied previously. Glucocorticoids (GCs) that are released in response to stress have been shown to be deleterious to neurons in various brain regions. Further, in the light of the effect of GCs on astrocytes, several reports have shown the crucial role of glia. Still, much remains to be done to understand the stress-astrocytes-glucocorticoid interactions associated with the pathological consequences of various CNS disorders. This review is an attempt to summarize the effects of GCs and stress on astrocytes and its implications in depression.
Citation: Pranav Chintamani Joshi, Sugato Benerjee. Effects of glucocorticoids in depression: Role of astrocytes[J]. AIMS Neuroscience, 2018, 5(3): 200-210. doi: 10.3934/Neuroscience.2018.3.200
Related Papers:
[1]
Mehmet Yavuz, Waled Yavız Ahmed Haydar .
A new mathematical modelling and parameter estimation of COVID-19: a case study in Iraq. AIMS Bioengineering, 2022, 9(4): 420-446.
doi: 10.3934/bioeng.2022030
[2]
Sarbaz H. A. Khoshnaw, Kawther Y. Abdulrahman, Arkan N. Mustafa .
Identifying key critical model parameters in spreading of COVID-19 pandemic. AIMS Bioengineering, 2022, 9(2): 163-177.
doi: 10.3934/bioeng.2022012
[3]
Bashdar A. Salam, Sarbaz H. A. Khoshnaw, Abubakr M. Adarbar, Hedayat M. Sharifi, Azhi S. Mohammed .
Model predictions and data fitting can effectively work in spreading COVID-19 pandemic. AIMS Bioengineering, 2022, 9(2): 197-212.
doi: 10.3934/bioeng.2022014
[4]
Sarbaz H. A. Khoshnaw, Azhi Sabir Mohammed .
Computational simulations of the effects of social distancing interventions on the COVID-19 pandemic. AIMS Bioengineering, 2022, 9(3): 239-251.
doi: 10.3934/bioeng.2022016
[5]
Ayub Ahmed, Bashdar Salam, Mahmud Mohammad, Ali Akgül, Sarbaz H. A. Khoshnaw .
Analysis coronavirus disease (COVID-19) model using numerical approaches and logistic model. AIMS Bioengineering, 2020, 7(3): 130-146.
doi: 10.3934/bioeng.2020013
[6]
Honar J. Hamad, Sarbaz H. A. Khoshnaw, Muhammad Shahzad .
Model analysis for an HIV infectious disease using elasticity and sensitivity techniques. AIMS Bioengineering, 2024, 11(3): 281-300.
doi: 10.3934/bioeng.2024015
[7]
Fırat Evirgen, Fatma Özköse, Mehmet Yavuz, Necati Özdemir .
Real data-based optimal control strategies for assessing the impact of the Omicron variant on heart attacks. AIMS Bioengineering, 2023, 10(3): 218-239.
doi: 10.3934/bioeng.2023015
[8]
Kranthi Kumar Lella, Alphonse PJA .
A literature review on COVID-19 disease diagnosis from respiratory sound data. AIMS Bioengineering, 2021, 8(2): 140-153.
doi: 10.3934/bioeng.2021013
[9]
Eduardo Federighi Baisi Chagas, Piero Biteli, Bruno Moreira Candeloro, Miguel Angelo Rodrigues, Pedro Henrique Rodrigues .
Physical exercise and COVID-19: a summary of the recommendations. AIMS Bioengineering, 2020, 7(4): 236-241.
doi: 10.3934/bioeng.2020020
[10]
Cong Toai Truong, Kim Hieu Huynh, Van Tu Duong, Huy Hung Nguyen, Le An Pham, Tan Tien Nguyen .
Model-free volume and pressure cycled control of automatic bag valve mask ventilator. AIMS Bioengineering, 2021, 8(3): 192-207.
doi: 10.3934/bioeng.2021017
Abstract
Astrocytes or astroglia are heterogeneous cells, similar to neurons, that have different properties in different brain regions. The implications of steroid hormones on glial cells and stress-related pathologies have been studied previously. Glucocorticoids (GCs) that are released in response to stress have been shown to be deleterious to neurons in various brain regions. Further, in the light of the effect of GCs on astrocytes, several reports have shown the crucial role of glia. Still, much remains to be done to understand the stress-astrocytes-glucocorticoid interactions associated with the pathological consequences of various CNS disorders. This review is an attempt to summarize the effects of GCs and stress on astrocytes and its implications in depression.
1.
Introduction
People always love to live healthy. But it was not expected all the time. Over many years, many diseases have been evolved. The root of many diseases are not still known. Some of the natural elements being spoiled by mankind, spoil the mankind in turn. Sometimes, diseases emerge naturally and in sometimes, it may be by a human error. Whatever it is, once a disease has arrived among the mankind, it will spread to maximum number of people irrespective of age, gender, country, etc. Today, mankind is facing one such deadly disease called coronavirus. Coronavirus is not an exception in causing major loss to the society as well as mankind. Its time to quarantine our self to save our precious life. Coronaviruses are actually a group of same kind of viruses. They affect birds and mammals highly. In human beings, these coronaviruses are causing toughness to breath. The respiratory infections caused by COVID-19 may be light, like common cold, or may be severe, like SARS, MERS, and novel corona. The medical world is still struggling to find the medicine that can treat these diseases. The spread of coronaviruses from one human to other is believed to spread among the close communities by means of sneezing or coughing or even by touching. The first human infecting coronaviruses were discovered during 1960. The very first one was found in chickens called as infectious-bronchitis-virus. The other two were found in human beings with common cold. It was named as human coronaviruses 229E and human coronaviruses OC43 later. Also, there are other lists of this coronavirus. They are SARS-CoV which was found in 2003. In the year 2004, HCoV NL63 was found. In the next year, 2005 HKU1 was found. MERS-CoV found in the year of 2012, and SARS-CoV-2 which was well known to be 2019-nCoV, found recently in the year 2019. Still new viruses are persisting in the globe. Most of these viruses have involved very serious problems such as respiratory problems and inner organ failure. Coronaviruses are classified in to four types and they are Alpha-coronaviruses, Beta-coronaviruses, Gamma-coronaviruses, and Delta-coronaviruses. From the observations, the bats, birds and all hot blooded creatures are the only hosts for the alpha and beta coronaviruses, and birds are common to gamma and delta coronaviruses for the evolution and spreading of these viruses. All coronaviruses may change in terms of their risk factor. More than 30% of those infected (such as MERS-CoV) may die and some others such as fever, dry cough and sore throat from swollen adenoids, occurring mostly in the winter and in spring seasons are less harmful. Coronaviruses are able to cause pneumonia and bronchitis. The most threaten human coronavirus was discovered in the year 2003, (SARS-CoV), which causes a severe acute respiratory syndrome called SARS. It has very unique pathogenesis infecting both upper and lower respiratory tracts. During the years of 2002–2004, it was found as 774 people had died of SARS-CoV. In 2012, 2015 and 2018 the MERS-CoV respectively caused over 400, 36 and 41 deaths. Now, during 2019 to 2020, coronavirus pandemic was considered as a global threat with at least 30,935 deaths till March 29 2020.
1.1. Coronavirus disease 2019 (COVID-19)
During December 2019, It was reported in Wuhan, China , a pneumonia type of disease outbreak. On 31 September 2019, that was traced and identified as a novel coronavirus. The World Health Organization (WHO) called it as 2019-nCoV. Later, the International Committee on Taxonomy of viruses called it as SARS-CoV-2. Since, March 29, 2020, there have been found at least 30,935 confirmed deaths and more than 492,571 confirmed cases in the coronavirus pandemic over 199 countries and territories around the world and two international conveyances, one is the Diamond Princess cruise ship of Japan and the other is Holland America's MS Zaandam Cruise ship. The Wuhan novel strain has been identified as a new type of Beta coronavirus and it was from group 2B with approximately 70% genetic similarity with SARS-CoV. As this virus has a 96% of similarity to bat coronaviruses, it was believed that these viruses start from bats. This pandemic has resulted in travel restrictions. Also worldwide, we can see lock-downs in several countries. Since modeling of any pandemic or epidemic disease spread is uncertain, there will be vagueness always. To overcome this vagueness and to study uncertainty, fuzzy sets was first introduced individually by Lofti A. Zadeh in 1965 [1]. Today randomness, vagueness and uncertainty problems were mostly studied everywhere like signal processing, artificial intelligence, population dynamics, optics, oriental medicine, by Engineers, Doctors and Scientists etc. Fuzzy sets, fuzzy differential equations, fuzzy logic are considered to be their important tools to study them. The imprecise nature of medical concepts are always defined with the help of fuzzy logic.
In [1] and [2], L.A. Zadeh, presented fuzzy sets, fuzzy mapping and control. In [3], J.J. Bukley and T. Feuring, in [4], D. Dubois and H. Prade, in [5], Lupulescu, in [6] and in [7], Kaleva did a great research on fuzzy differential equations. In [8], Ma, Friedman and Kandel, and in [9], seikkala, provided a great contribution to fuzzy differential equations, fuzzy differential calculus, fuzzy initial value problem and seikkala dervative is the predominant work of Seikkala in the fields of fuzzy differential equations. In [10], Diamond and Kloedan analyzed metric spaces of fuzzy sets in 1984. In [11], Y. Chalco-Cano and H. Roman-Flores, defined, analyzed and studied new solutions of fuzzy differential equations. In [12] and [13], S. Abbasbandy and T. Allahviranloo, studied numerical solution of fuzzy differential equation by Taylor method and by Runge-Kutta method. In [14], C.F. Curtiss, J.O. Hirschfelder, studied integration of stiff equations. In [15], Gustaff Soderlind, Laurent Jay and Manual Calvo, published a work on Stiffness. In [16], L. Shampine, provided evaluation of a test set for stiff ODE solvers. In [17], D.J. Higham and L.N Trefethen studied stiffness of ODEs. In [18], M.N. Spijker, evaluated stiffness in numerical initial value problems.
In [19], W.O. Kermack and A.G. Mckendrick, gave the first contribution to the mathematical theory of epidemics. In [20], P. Palese and J.F. Young, studied variation of Influenza A, B, and C. In [21], Allen LJS gave an introduction to mathematical biology in 2007. In [22], Sha He, Sanyi Tang and Libinin Rong, framed a discrete stochastic model for COVID-19 outbreak: forecast and control. In [23], Weike zhou, Aili Wang, Fan Xia, Yanni Xiao and Sanyi Tang reported the effects of media on mitigating spread of COVID-19 in the early phase of the outbreak. In [24], Fuliyan Yin, Jiahui Lv, Xiaojian Zhang, Xinyu Xia, and Jianhong Wu, presented COVID-19 information propagation dynamics in the chinese sina-microblog. In [25], Chenxi Dai, Jing Yang and Kaifa Wang, did evaluation of control interventions on the epidemic of coronavirus disease 2019 in Chongqing and Guizhou Provinces. In [26], Xinmiao Rong, Liu Yang, Huidi Chu and Meng Fan, analyzed the effect of delay in diagnosis on spread of coronavirus. In [27], Jingjing Tian, Jiabing wu, Yunting Bao, Xiaoyu Weng, Lei Shi, Binbin Liu, Xinya Yu, did modeling analysis of COVID-19 in Anhui, China. In [28], Chentong Li, Jinhu Xu, Jiawei Liu and Yicang Zhou, particularly studied the within-host viral kinetics COVID-19. In [29], Vitaly Volpert, Malay Banerjee and Sergei Petrovskii, gave their tremendous work on a quarantine model of coronavirus infection along with data analysis. In [30], Biao Tang, Nicola Luigi Bragazzi, Qian Li, Sanyi Tang, Yanni Xiao and Jianhong Wu analysed and provided an updated estimation of the novel coronavirus transmission. Zifeng Yang et al. analysed modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions in [31]. ShreshthTuli, Shikhar Tuli et al. predicted the growth and trend of COVID-19 pandemic using machine learning and cloud computing in [32]. Chintamani Pai et al. investigated the dynamics of COVID-19 pandemic in India under lockdown in [33]. Matheus Henrique Dal Molin Ribeiro et al. focused on short-term forecasting COVID-19 cumulative confirmed cases: perspectives for Brazil in [34]. Muhammad Altaf Khan and Abdon Atangana, have modeled the dynamics of novel coronavirus (2019-nCov) with fractional derivative in [35]. In [36], [37], [38] and [39], authors like Muhammad Altaf Khan regularly studied SEIR, dengue and also presented the numerical solution of the competition model among bank data in Caputo-Fabrizio derivative. Authors of [40], [41] and [42] have regularly studied numerical solutions of fuzzy differential equations.
The paper contains preliminaries, which are essential to create some basic knowledge about the study to the readers, in section 2. The remainder of the paper is structured as follows. The formulation of models in terms of ordinary differential equations and in terms of fuzzy differential equations are given in section 3. Stability analysis and test for given system to be stiff differential equations are performed in section 4. Numerical simulation of infected, recovered and death cases are presented in terms of both ordinary differential equations and fuzzy differential equations in section 5.
2.
Preliminaries
Before proceeding to some of the prerequisites necessary for the study, we are now presenting the novelty, new contributions and new objectives in this paper which will motivate the readers and researchers. This is the first paper in which the epidemic modeling without considering the susceptible population was framed. This is the first paper in which the stiff differential equations and fuzzy properties are used to frame and study such a model. Many papers are emerging daily to predict the daily cases but this is the first paper in which a new idea called maintaining the 14 day average-infectious, recovered and death populations under threshold populations is given to control the spread and human loss. Also in this paper since susceptible population was not considered, we are introducing the new number called average transmission number-N0 instead of basic reproduction number R0. For each country this modeling could be applied as here we are studying globally. In mathematical biology point of view, the advantage of models framed by stiff fuzzy differential equations is used to analyze the model in which the stiffness (stiffness is defined below) arise can be set under fuzzy boundary so that values are predicted at crisp set values and analyzed at the fuzzy set values. That will help us to set the boundary of our analyze to two extreme (minimum and maximum) values and also to the in between values (partial member values). All these are explained in detail below.
2.1. Stiff differential equations
Though stiff differential equations are most important field of research in mathematical modeling, a rigorous, efficient, meaningful and computationally relevant properties or definition of stiffness is still not well defined. Since many years, many different numerical methods and software codes have been designed for the efficient solution of stiff initial value problem. The seminal paper of curtiss and Hirchfelder [14] first opened this field, stiffness. But it was not yet properly defined. According to Shampine [16], “A major difficulty is that stiffness is a complex of related phenomena, so that it is not easy to define what stiffness is”.
Stiff equations are some of the problems in ordinary differential equations for which explicit type of numerical methods does not work. The explicit type of numerical methods may struggle a lot when applied to the IVP's (initial value problems) ˙y=f(y), y(0) = y0. It is always not possible to solve, when f′(y) is very large. Similarly in non linear equations, fixed point iteration ym+1 = f(ym) does not converge for problems whose f′(y) is large. Curtiss and Hirchfelder [14] are the two people who introduced the notation stiffness for which the explicit methods for numerical solutions of ordinary differential equations failed. There is no unique definition of stiffness is found in the literature. But one can call the system of ordinary differential equations is called stiff if Lipschits constant L defined for solution over the interval is L(y0, yn)>>1.
The following is the definition of stiff system of fuzzy differential equations.
Definition 2.1 (Stiff system of fuzzy differential equations). The linear system of fuzzy differential equations˜y′(x)=A˜y(x),A∈Rn×n, is known as fuzzy stiff, if all eigenvalues λi posses a negative real part and if
The stiff differential equations are numerically known to be unstable unless the step size is extremely very very small.
Stiff differential equations are also characterized as one for which exact solution possessed to have a term of the form e−kt, where k is a large positive constant.
Large derivatives of e−kt always give error terms and that will always dominate the solutions.
2.2. Fuzzy differential equations
We are interested to study the model in fuzzy differential equations because, it only studies the system completely as non-member, partial members and full member. If y0 is a fuzzy number found with α-level of intervals [y0]α=[y¯α,ˉyα],0≤α≤1. The extension principle of Zadeh leads us to the following definition of ˜f(t,y(t)) when y is a fuzzy number.
for y∈E with α-level sets [y]α=[y¯αt,ˉyαt],0≤α≤1 since the fuzzy derivative y′(t) of a fuzzy process, y:R+→E is defined by [y′(t)]α=[(y¯α)′(t),(ˉyα)′(t)],0≤α≤1.
We call y:R+→E a fuzzy solution of (2.1) on the interval I = [0,t] if
for t∈I and 0≤α≤1 Thus for fixed α we have an initial value problem in R2. If we can solve it, we have only to verify that intervals [yαt,ˉyαt],0≤α≤1, define a fuzzy number y(t)∈E.
3.
Model formulation
As COVID-19 is pandemic and spreads in several countries of the world very quickly, we are unable to know the exact count of susceptible population. The infected, recovered and dead populations were taken from various online resources like [43]. In order to frame the model, we have taken the data from March 10 to March 23, 2020. All the existing mathematical models deals with growth of the disease day by day and there is no model yet without susceptible population, also they require the susceptible population to calculate the basic reproduction number. Here we take 14 days data of the whole world's COVID-19 cases and take their average as the initial population. The worlds population is very high and the disease is spreading in a very fast manner. so the population of infected, recovered and dead was also increasing day by day. We have to keep in mind that the worlds total population cannot be taken as susceptible. Anyone with common symptoms of the disease but not yet infected is what exactly susceptible population mean. Due to lack of awareness about the symptoms no one can visit the hospital. In such situation its not possible to record the exact population of susceptible cases as recording the exact population of infected, recovered and dead. So we are interested to create a model called IRD-Infected, Recovered and Dead. Since the disease has an average life of 14 days we are also interested to study the average cases of IRD population over 14 days mean. It is quite interesting to study such new way of modeling. In future many researchers may interested to study the model like this. The main advantage of studying this average transmission model is one can easily estimate the average change in population for any years. But the average number should be the life of virus. Before presenting the model, the data from March 10 to March 23, 2020 are presented.
Let β, μ, γ and ζ be the rate of infected I(t), recovered R(t), Death D(t) and the total cases T(t) respectively. We know that the rate of total case is always 100. i.e., ζ = 100.
Table 1.
COVID-19, 14 days population and rates [43].
From the above table it was found that I(t), R(t) and D(t) increases rapidly and also it is clear that I(t) > R(t) > D(t) and obviously β>μ>γ. But without considering from the table we shall calculate β, μ and γ using separate forumalae later. So the COVID-19 model is the exponentially growing model. Since the spread of this pandemic disease is not coming to an end or any proper medicine was not yet found it is not a right way to go for the logistic growth model. If so, what will be the carrying capacity, as total population and susceptible population are not clearly known? Biologist and Doctors says the average life of this COVID-19 is 14 days. At least we can check whether its average population model is growing exponentially or not. If this is not growing exponentially then we can suggest doctors to maintain this average initial populations as threshold numbers. Exceeding this may lead to loss the control of infections and deaths. Through out the paper, Δ represents rate of change in population of Infected, Recovered and Dead cases with respect to time t and D represents death population. With these ideas the following model is made.
As already discussed, β, μ and γ be the rate of healthy become infected (I(t)), infected become recovered (R(t)), infected become death (D(t)) respectively. Mathematically death is similar to recovered because both are infection free. The average rate of infectious become death are given by γI(t)D(t). The average rate of infectious become recovered and recovered become infectious are given by μI(t)R(t) and βI(t)R(t). The average rate of recovered become death are represented in two ways as γR(t)D(t) to study death during infection or partial recovery and μR(t)D(t) to study death after being recovered, i.e., natural death.
For any value t0≤t≤tn, β−μR(t)−γD(t)<0, μI(t)−βI(t)−γD(t)<0, γ−μR(t)<0 which produces ce(−ve) values as the solutions of (3.1) Thus we call the model (3.1) as system of stiff differential equations. We shall present the test later to confirm it. Now fuzzy system of stiff differential equation are given in (3.2).
The rate of infection, recovered and death are also found by average of ratios of 14 days. Instead of taking β, μ and γ from the Table 1, we are calculating them using more appropriate formulae given below.
β→the rate of infection=Infected case×ζ/total case
μ→the rate of recovery=Recovered case×ζ/total case
γ→the rate of death=death case×ζ/total case
ζ→the rate of total case.
The total case T(t)=Infected case I(t)+Recovered case R(t)+Death case D(t)=206638 at t=t0
T′(t)=I′(t)+R′(t)+D′(t)
Now we consider the average of those 14 days rate as the required rate.
We found that β=56, μ=40, γ=4 and ζ=100.
4.
Stability analysis and stiff system test
4.1. Equilibrium points
The equilibrium points are found by setting Δ˜I(t)=0, Δ˜R(t)=0 and Δ˜D(t)=0. The disease free equilibrium points are (0,0,0) and the disease depending equilibrium points are given by (γ−βμ−β,γμ,1−βγ) thus the values of disease depending equilibrium points are (3.25,0.1,−13).
4.2. Average transmission number: N0
The average transmission number is the number telling the average spread of disease from one to others. Though it is similar to basic reproduction number R0, we are not using susceptible population here. That's why we are calling it by a different name “average transmission number N0”. The calculation of basic reproduction number requires the population of susceptible case. Since we are not aware of susceptible population, we are introducing this new method for calculating this new number called average transmission number. It is a two step method.
From the above average transmission number, we can easily assert that this 14 day average pandemic COVID-19 is spreading from infected one to at least 1 person or to at most 4 persons. This number N0 found from this new method matches with universally accepted basic reproduction number R0 of COVID-19.
4.3. Stability analysis using eigen values
Theorem 4.1.When all the eigen values of linearized form of(3.2)are < 0. Then the model considered is asymptotically stable.
Proof. Let us first linearize the model (3.2) in the form of Jacobian matrix and name it as A
On substituting the values of all the parameters and solving (4.2), the characteristic polynomial was found to be λ3+8515964λ2+17276845232848λ+422461568851044800=0
Since all the eigen values have the negative real parts, the system we considered is asymptotically stable.
4.4. Stiff system of fuzzy differential equation-test
Theorem 4.2.Stiffness test by eigen values
By the definiton 2.1, a linear fuzzy system or a linearized form of a non linear fuzzy system posses negative real parts in all its eigen values and satisfying
The (4.2) satisfied the theorem and hence our model (3.2) is the stiff system of fuzzy differential equations which obviously establishes that (3.1) is the stiff system of differential equations.
5.
Numerical simulations
Since the model we considered is a stiff system of differential equations, we do not prefer to use Runge-Kutta methods or any other numerical methods. As already discussed the exact solutions of ˜I(t),˜R(t),˜D(t) are in the form e(−ve) value. Also those negative values are high requiring very precise small step size which will lead to more number of iterations. So it was found that numerical methods like Runge-Kutta methods are not stable to study any stiff differential equations like (3.1).
So going for software is the better option. Software like Mathematica, Matlab, Maple etc., having build in functions are effective to provide best approximate solutions. We obtain the numerical solutions of both ordinary and fuzzy valued model by using the NDSolve technique of Mathematica software to solve differential equations.
The following plots will be useful to check the average of 14 days pandemic transmission. The plots for March 10 to March 23 are not provided since seeing the table itself we can understand that all the cases like susceptible, infected and recovered are increasing like exponential growth. Without any logistic term to control the growth, the average population itself is giving the stable graphs, which means they are our threshold populations. The graphical representations are given for very minimum time span i.e., 0.00001 days or 0.864 seconds in order to zoom and show how the spread of diseases and each population changes are decreased. Also the main idea is to set a threshold population up to which the spread is under control and possible to completely remove the infection from the globe.
Figure 2.
Infected case for every 0.864 seconds (0.00001 days).
Without susceptible population a new model, say IRD-Infection-Recovered and Death model of 14 day average transmission of COVID 19 pandemic system was formulated. It was reformulated as fuzzy system of differential equations. The equilibrium points have been found and stability analysis was done by studying the eigen values. We have given the new method for calculating the new number called average transmission number N0 which matches with existing result of basic reproduction number R0. Also we proved that the system considered was stiff system of differential equations as well as stiff system of fuzzy differential equations. From the Table 1, we can see the system is exponentially growing day by day. As a sample, we took the data from March 10, 2020 to March 23, 2020. Since ˜I(t), ˜R(t) and ˜D(t) are growing exponentially, we took the average of those 14 days as our initial populations, say ˜I(t0), ˜R(t0) and ˜D(t0). Also their respective rates are found. From the plots Figures 2–4, we have shown in 0.00001 days (0.864 seconds) in average of 14 days, the cases approaching zero. This means for these initial populations the system produces a stable graph and approaches to zero in every 0.864 seconds per day of 14 day average is clearly noticed in plots. This study makes us to suggest the medical world to fix the threshold population of infectious, recovered and death cases under I(t)=115482, R(t)=82487 and D(t)=8669 and their rates under β=56, μ=40 and γ=4. So that, the whole world will easily overcome this deadly disease COVID-19. If the next 14 day average exceeds this threshold population, then it will make the disease to quickly spread and infect everyone in the globe. The respective fuzzy plots were given in Figures 5–7 for 86400 seconds. i.e., for a day.
In this work, instead of prediction we had founded the threshold numbers maintaining under which will reduce the spread of disease and the number of deaths due to it. But as a future work we are going to predict and compare the growth of new daily cases using commonly used metrics for comparison like mean average precision error, regularized R squared values. This stiff fuzzy model is used here to bound the unbound disease growth by setting 0≤α≤1 depending on which the stiff model will actively work with the boundary framed by 0≤α≤1. This is not the predictive analysis or comparison tool with daily cases data. This stiff fuzzy model is used to analyze the present spread of disease as three cases such as inactive hosts, partially active hosts and completely active hosts. It will be thus useful to confidently propose the threshold number from which medical world and government will get benefited by setting the every 14 day average IRD populations under this threshold number to control the disease and the deaths due to this pandemic disease COVID-19.
References
[1]
Volterra A, Magistretti PJ, Haydon PG (2002) The tripartite synapse: Glia in synaptic transmission. New York: Oxford University Press.
[2]
Pelvig DP, Pakkenberg H, Stark AK, et al. (2008) Neocortical glial cell numbers in human brains. Neurobiol Aging 29: 1754–1762. doi: 10.1016/j.neurobiolaging.2007.04.013
[3]
Ge WP, Jia JM (2016) Local production of astrocytes in the cerebral cortex. Neuroscience 323: 3–9. doi: 10.1016/j.neuroscience.2015.08.057
[4]
Hertz L (2008) Bioenergetics of cerebral ischemia: A cellular perspective. Neuropharmacology 55: 289–309. doi: 10.1016/j.neuropharm.2008.05.023
[5]
Bröer S, Brookes N (2001) Transfer of glutamine between astrocytes and neurons. J Neurochem 77: 705–719. doi: 10.1046/j.1471-4159.2001.00322.x
[6]
Halassa MM, Fellin T, Haydon PG (2007) The tripartite synapse: Roles for gliotransmission in health and disease. Trends Mol Med 13: 54–63. doi: 10.1016/j.molmed.2006.12.005
[7]
Nualart-Marti A, Solsona C, Fields RD (2013) Gap junction communication in myelinating glia. Biochim Biophys Acta 1828: 69–78. doi: 10.1016/j.bbamem.2012.01.024
[8]
Cabezas R, Avila M, Gonzalez J, et al. (2014) Astrocytic modulation of blood brain barrier: Perspectives on Parkinson's disease. Front Cell Neurosci 8: 211.
[9]
Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21: 55–89.
[10]
Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5: 374–381. doi: 10.1038/nrendo.2009.106
[11]
De Kloet ER, Van Acker SA, Sibug RM, et al. (2000) Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57: 1329–1336. doi: 10.1046/j.1523-1755.2000.00971.x
[12]
Carter BS, Meng F, Thompson RC (2012) Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro. Physiol Genomics 44: 1188–1200. doi: 10.1152/physiolgenomics.00097.2012
[13]
Mcewen BS (2005) Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism 54: 20–23. doi: 10.1016/j.metabol.2005.01.008
[14]
Green KN, Billings LM, Roozendaal B, et al. (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26: 9047–9056. doi: 10.1523/JNEUROSCI.2797-06.2006
Cobb J, O'Neill K, Milner J, et al. (2016) Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience 316: 209–220. doi: 10.1016/j.neuroscience.2015.12.044
[17]
Vyas S, Rodrigues AJ, Silva JM, et al. (2016) Chronic stress and glucocorticoids: From neuronal plasticity to neurodegeneration. Neural Plast 2016: 6391686.
[18]
Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: The revolution continues. Nat Rev Neurosci 6: 626–640. doi: 10.1038/nrn1722
[19]
Koyama Y (2015) Functional alterations of astrocytes in mental disorders: Pharmacological significance as a drug target. Front Cell Neurosci 9: 261.
[20]
Carter BS (2013) Glucocorticoid regulation of the astrocyte transcriptome in vitro and in vivo. University of Michigan.
Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45: 1085–1098. doi: 10.1016/S0006-3223(99)00041-4
[23]
Stockmeier CA, Mahajan GJ, Konick LC, et al. (2004) Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 56: 640–650. doi: 10.1016/j.biopsych.2004.08.022
[24]
Rajkowska G, Stockmeier CA (2013) Astrocyte pathology in major depressive disorder: Insights from human postmortem brain tissue. Curr Drug Targets 14: 1225–1236. doi: 10.2174/13894501113149990156
[25]
Verkhratsky A, Rodriguez JJ, Parpura V (2013) Astroglia in neurological diseases. Future Neurol 8: 149–158. doi: 10.2217/fnl.12.90
[26]
Banasr M, Duman RS (2008) Glial Loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 64: 863–870. doi: 10.1016/j.biopsych.2008.06.008
[27]
Czeh B, Simon M, Schmelting B, et al. (2005) Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31: 1616–1626.
[28]
Banasr M, Chowdhury GMI, Terwilliger R, et al. (2010) Glial pathology in an animal model of depression: Reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15: 501–511. doi: 10.1038/mp.2008.106
[29]
Messing A, Brenner M (2003) GFAP: Functional implications gleaned from studies of genetically engineered mice. Glia 43: 87–90. doi: 10.1002/glia.10219
[30]
Miguel-Hidalgo JJ, Baucom C, Dilley G, et al. (2000) Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 48: 861–873. doi: 10.1016/S0006-3223(00)00999-9
[31]
Bowley MP, Drevets WC, Ongur D, et al. (2002) Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 52: 404–412. doi: 10.1016/S0006-3223(02)01404-X
[32]
Polyakova M, Sander C, Arelin K, et al. (2015) First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression. Front Cell Neurosci 9: 406.
[33]
Benton CS, Miller BH, Skwerer S, et al. (2012) Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology 221: 297–315. doi: 10.1007/s00213-011-2574-z
[34]
Chandley MJ, Szebeni K, Szebeni A, et al. (2013) Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J Psychiatry Neurosci 38: 276–284. doi: 10.1503/jpn.120110
[35]
Bernard R, Kerman IA, Thompson RC, et al. (2011) Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16: 634–646. doi: 10.1038/mp.2010.44
[36]
Seifert G, Schilling K, Steinhäuser C (2006) Astrocyte dysfunction in neurological disorders: A molecular perspective. Nat Rev Neurosci 7: 194. doi: 10.1038/nrn1870
[37]
Choudary P, Molnar M, Evans S, et al. (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci 102: 15653–15658. doi: 10.1073/pnas.0507901102
[38]
Sun JD, Liu Y, Yuan YH, et al. (2012) Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 37: 1305–1320. doi: 10.1038/npp.2011.319
[39]
Bechtholt-Gompf AJ, Walther HV, Adams MA, et al. (2010) Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 35: 2049–2059. doi: 10.1038/npp.2010.74
[40]
de Vasconcellos-Bittencourt AP, Vendite DA, Nassif M, et al. (2011) Chronic stress and lithium treatments alter hippocampal glutamate uptake and release in the rat and potentiate necrotic cellular death after oxygen and glucose deprivation. Neurochem Res 36: 793–800. doi: 10.1007/s11064-011-0404-7
[41]
Almeida RF, Thomazi AP, Godinho GF, et al. (2010) Effects of depressive-like behavior of rats on brain glutamate uptake. Neurochem Res 35: 1164–1171. doi: 10.1007/s11064-010-0169-4
[42]
Bechtholt-Gompf AJ, Walther HV, Adams MA, et al. (2010) Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 35: 2049–2059. doi: 10.1038/npp.2010.74
[43]
Lapidus KA, Soleimani L, Murrough JW (2013) Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatr Dis Treat 9: 1101–1112.
[44]
Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62: 63–77. doi: 10.1016/j.neuropharm.2011.07.036
[45]
Paslakis G, Gass P, Deuschle M (2011) [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: Preclinical and clinical data]. Fortschr Neurol Psychiatr 79: 204–212. doi: 10.1055/s-0029-1245770
[46]
Rial D, Lemos C, Pinheiro H, et al. (2015) Depression as a glial-based synaptic dysfunction. Front Cell Neurosci 9: 521.
[47]
Jo WK, Zhang Y, Emrich HM, et al. (2015) Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci 9: 268.
[48]
Brites D, Fernandes A (2015) Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation. Front Cell Neurosci 9: 476.
[49]
Quesseveur G, Portal B, Basile JA, et al. (2015) Attenuated Levels of Hippocampal Connexin 43 and its Phosphorylation Correlate with Antidepressant- and Anxiolytic-Like Activities in Mice. Front Cell Neurosci 9: 490.
[50]
Jeanson T, Pondaven A, Ezan P, et al. (2015) Antidepressants Impact Connexin 43 Channel Functions in Astrocytes. Front Cell Neurosci 9: 495.
[51]
Fuchs E, Flugge G (2003) Chronic social stress: Effects on limbic brain structures. Physiol Behav 79: 417–427. doi: 10.1016/S0031-9384(03)00161-6
[52]
Gould E, Tanapat P (1999) Stress and hippocampal neurogenesis. Biol Psychiatry 46: 1472–1479. doi: 10.1016/S0006-3223(99)00247-4
[53]
Rajkowska G, Miguel-Hidalgo JJ (2007) Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6: 219–233. doi: 10.2174/187152707780619326
[54]
Wang Q, Verweij EW, Krugers HJ, et al. (2014) Distribution of the glucocorticoid receptor in the human amygdala; changes in mood disorder patients. Brain Struct Funct 219: 1615–1626. doi: 10.1007/s00429-013-0589-4
[55]
Czeh B, Muller-Keuker JI, Rygula R, et al. (2007) Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: Hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 32: 1490–1503. doi: 10.1038/sj.npp.1301275
[56]
Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50: 427–434. doi: 10.1002/glia.20207
[57]
Rozovsky I, Laping NJ, Krohn K, et al. (1995) Transcriptional regulation of glial fibrillary acidic protein by corticosterone in rat astrocytes in vitro is influenced by the duration of time in culture and by astrocyte-neuron interactions. Endocrinology 136: 2066–2073. doi: 10.1210/endo.136.5.7720656
[58]
O'Callaghan JP, Brinton RE, Mcewen BS (1991) Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J Neurochem 57: 860–869. doi: 10.1111/j.1471-4159.1991.tb08230.x
[59]
Bridges N, Slais K, Sykova E (2008) The effects of chronic corticosterone on hippocampal astrocyte numbers: A comparison of male and female Wistar rats. Acta Neurobiol Exp 68: 131–138.
[60]
Lambert KG, Gerecke KM, Quadros PS, et al. (2000) Activity-stress increases density of GFAP-immunoreactive astrocytes in the rat hippocampus. Stress 3: 275–284. doi: 10.3109/10253890009001133
[61]
Leventopoulos M, Ruedi-Bettschen D, Knuesel I, et al. (2007) Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res 1142: 119–126. doi: 10.1016/j.brainres.2007.01.039
[62]
Fields RD, Stevens-Graham B (2002) New insights into neuron-glia communication. Science 298: 556–562. doi: 10.1126/science.298.5593.556
Conrad CD (2006) What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus? Behav Cogn Neurosci Rev 5: 41–60. doi: 10.1177/1534582306289043
[65]
Autry AE, Grillo CA, Piroli GG, et al. (2006) Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression in the rat hippocampus. Neuroendocrinology 83: 371–379. doi: 10.1159/000096092
[66]
Horner HC, Packan DR, Sapolsky RM (1990) Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52: 57–64. doi: 10.1159/000125539
[67]
Ritchie LJ, De Butte M, Pappas BA (2004) Chronic mild stress exacerbates the effects of permanent bilateral common carotid artery occlusion on CA1 neurons. Brain Res 1014: 228–235. doi: 10.1016/j.brainres.2004.04.036
[68]
Kroll S, El-Gindi J, Thanabalasundaram G, et al. (2009) Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit. Ann N Y Acad Sci 1165: 228–239. doi: 10.1111/j.1749-6632.2009.04040.x
[69]
Donato R (2001) S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637–668. doi: 10.1016/S1357-2725(01)00046-2
[70]
Bruschettini M, van den Hove DL, Gazzolo D, et al. (2005) A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat. Brain Res Dev Brain Res 159: 113–118. doi: 10.1016/j.devbrainres.2005.07.003
[71]
Margis R, Zanatto VC, Tramontina F, et al. (2004) Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Res 1028: 213–218. doi: 10.1016/j.brainres.2004.09.013
[72]
Scaccianoce S, Del BP, Pannitteri G, et al. (2004) Relationship between stress and circulating levels of S100B protein. Brain Res 1004: 208–211. doi: 10.1016/j.brainres.2004.01.028
[73]
Niu H, Hinkle DA, Wise PM (1997) Dexamethasone regulates basic fibroblast growth factor, nerve growth factor and S100beta expression in cultured hippocampal astrocytes. Brain Res Mol Brain Res 51: 97–105. doi: 10.1016/S0169-328X(97)00221-0
[74]
Bazargani N, Attwell D (2016) Astrocyte calcium signaling: the third wave. Nat Neurosci 19: 182–189. doi: 10.1038/nn.4201
Mcleod JD, Bolton C (1995) Dexamethasone induces an increase in intracellular and membrane-associated lipocortin-1 (annexin-1) in rat astrocyte primary cultures. Cell Mol Neurobiol 15: 193–205. doi: 10.1007/BF02073328
[77]
Lindholm D, Castren E, Hengerer B, et al. (1992) Differential Regulation of Nerve Growth Factor (NGF) Synthesis in Neurons and Astrocytes by Glucocorticoid Hormones. Eur J Neurosci 4: 404–410. doi: 10.1111/j.1460-9568.1992.tb00889.x
[78]
Yuan SY, Liu J, Zhou J, et al. (2016) AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes. PLoS One 11: e0159513. doi: 10.1371/journal.pone.0159513
[79]
Chen J, Wang ZZ, Zuo W, et al. (2016) Effects of chronic mild stress on behavioral and neurobiological parameters-Role of glucocorticoid. Horm Behav 78: 150–159. doi: 10.1016/j.yhbeh.2015.11.006
[80]
Karisetty BC, Joshi PC, Kumar A, et al. (2017) Sex differences in the effect of chronic mild stress on mouse prefrontal cortical BDNF levels: A role of major ovarian hormones. Neuroscience 356: 89–101. doi: 10.1016/j.neuroscience.2017.05.020
[81]
Bender CL, Calfa GD, Molina VA (2016) Astrocyte plasticity induced by emotional stress: A new partner in psychiatric physiopathology? Prog Neuropsychopharmacol Biol Psychiatry 65: 68–77. doi: 10.1016/j.pnpbp.2015.08.005
[82]
Anacker C, Cattaneo A, Luoni A, et al. (2013) Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology 38: 872–883. doi: 10.1038/npp.2012.253
[83]
Van DL, Steinbusch HW, Bruschettini M, et al. (2006) Prenatal stress reduces S100B in the neonatal rat hippocampus. Neuroreport 17: 1077–1080. doi: 10.1097/01.wnr.0000223391.74575.c9
[84]
Nichols NR, Agolley D, Zieba M, et al. (2005) Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration. Brain Res Rev 48: 287–301. doi: 10.1016/j.brainresrev.2004.12.019
This article has been cited by:
1.
Saeed Ahmad, Saud Owyed, Abdel-Haleem Abdel-Aty, Emad E. Mahmoud, Kamal Shah, Hussam Alrabaiah,
Mathematical analysis of COVID-19 via new mathematical model,
2021,
143,
09600779,
110585,
10.1016/j.chaos.2020.110585
2.
Abdon Atangana, Seda İğret Araz,
Mathematical model of COVID-19 spread in Turkey and South Africa: theory, methods, and applications,
2020,
2020,
1687-1847,
10.1186/s13662-020-03095-w
3.
Isa Abdullahi Baba, Abdullahi Yusuf, Kottakkaran Sooppy Nisar, Abdel-Haleem Abdel-Aty, Taher A. Nofal,
Mathematical model to assess the imposition of lockdown during COVID-19 pandemic,
2021,
20,
22113797,
103716,
10.1016/j.rinp.2020.103716
4.
Prasantha Bharathi Dhandapani, Jayakumar Thippan, Dumitru Baleanu, Vinoth Sivakumar,
On a novel fuzzy fractional retarded delay epidemic model,
2022,
7,
2473-6988,
10122,
10.3934/math.2022563
5.
Prasantha Bharathi Dhandapani, Dumitru Baleanu, Jayakumar Thippan, Vinoth Sivakumar,
New Fuzzy Fractional Epidemic Model Involving Death Population,
2021,
37,
0267-6192,
331,
10.32604/csse.2021.015619
6.
Maheswari Rangasamy, Nazek Alessa, Prasantha Bharathi Dhandapani, Karuppusamy Loganathan,
Dynamics of a Novel IVRD Pandemic Model of a Large Population over a Long Time with Efficient Numerical Methods,
2022,
14,
2073-8994,
1919,
10.3390/sym14091919
7.
Kalpana Umapathy, Balaganesan Palanivelu, Renuka Jayaraj, Dumitru Baleanu, Prasantha Bharathi Dhandapani,
On the decomposition and analysis of novel simultaneous SEIQR epidemic model,
2022,
8,
2473-6988,
5918,
10.3934/math.2023298
8.
Emmanuel A. Bakare, Snehashish Chakraverty, Radovan Potucek,
Numerical Solution of an Interval-Based Uncertain SIR (Susceptible–Infected–Recovered) Epidemic Model by Homotopy Analysis Method,
2021,
10,
2075-1680,
114,
10.3390/axioms10020114
9.
Maheswari Rangasamy, Christophe Chesneau, Carlos Martin-Barreiro, Víctor Leiva,
On a Novel Dynamics of SEIR Epidemic Models with a Potential Application to COVID-19,
2022,
14,
2073-8994,
1436,
10.3390/sym14071436
10.
Prasantha Bharathi Dhandapani, Víctor Leiva, Carlos Martin-Barreiro, Maheswari Rangasamy,
On a Novel Dynamics of a SIVR Model Using a Laplace Adomian Decomposition Based on a Vaccination Strategy,
2023,
7,
2504-3110,
407,
10.3390/fractalfract7050407
11.
Shomaila Mazhar, Zahid Ullah, Syed Inayat Ali Shah, Noor Badshah,
Development of a probabilistic model for Covid-19 dynamics with consideration of non-severe and severe infections,
2023,
82,
11100168,
126,
10.1016/j.aej.2023.09.067
Pranav Chintamani Joshi, Sugato Benerjee. Effects of glucocorticoids in depression: Role of astrocytes[J]. AIMS Neuroscience, 2018, 5(3): 200-210. doi: 10.3934/Neuroscience.2018.3.200
Pranav Chintamani Joshi, Sugato Benerjee. Effects of glucocorticoids in depression: Role of astrocytes[J]. AIMS Neuroscience, 2018, 5(3): 200-210. doi: 10.3934/Neuroscience.2018.3.200
Figure 1. Astrocytic changes in the depressed brain. The crosstalk between the astrocytes and neurons is mediated at the tripartite synapse: A) Astrocyte marker GFAP and cytoplasmic protein S100β expression may alter with depression. B) Astrocyte-specific gap junction protein (Cx43) may alter during stress and depression. C) The water channel marker, AQP4 protein levels is found to reduce in depression. D and E) The expression of certain astrocyte glutamate transporters, as well as glutamine synthase may reduce in MD patients. F) There may be up-regulation of the hippocampal glial glutamate transporter (GLT-1) after chronic stress. G) Astrocytes may also coordinate their function through Ca2+ excitability and its downstream signaling in depression